NEW YORK, Dec. 13 — Q3DM will collaborate with the Genomics Institute of the Novartis Research Foundation in order to develop multiple assays on its high-throughput microscopy platform, the company said Thursday.

The company and the institute will jointly develop a suite of applications for high-throughput cell-based screening, and develop for commercialization a set of assays, reagents, and software products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.